What people with Down Syndrome can teach us about cardiopulmonary disease

Kelley L Colvin1,2,3, Michael E Yeager4,2,3

  • 1Dept of Bioengineering, University of Colorado Denver, Aurora, CO, USA.

Insights

Individuals with Down syndrome face significant health challenges, including cardiovascular, respiratory, and immune issues. Understanding the genetic basis of these conditions is crucial for developing new treatments and improving quality of life.

Area of Science:

  • Genetics
  • Immunology
  • Cardiology
  • Pulmonology

Background:

  • Down syndrome, caused by trisomy 21, is the most common chromosomal abnormality in live-born infants.
  • It is associated with cognitive impairment, congenital malformations (especially cardiovascular), and dysmorphic features.
  • Immune disturbances contribute significantly to the disease burden, including autoimmune conditions and increased susceptibility to infections.

Purpose of the Study:

  • To review the cardiovascular, respiratory, and immune challenges in individuals with Down syndrome.
  • To explore the genetic underpinnings of these pathobiologies.
  • To advocate for comparative studies to advance prevention and treatment strategies.

Main Methods:

  • This is a review article, synthesizing existing research on Down syndrome.
  • It focuses on summarizing known information regarding cardiovascular, respiratory, and immune system complications.
  • Genetic factors contributing to the observed pathologies are discussed.

Main Results:

  • Cardiovascular and pulmonary diseases are major causes of mortality, accounting for approximately 75% of deaths in individuals with Down syndrome.
  • Immune dysregulation leads to a wide spectrum of health issues, from quality-of-life problems to life-threatening conditions.
  • Cognitive impairment and dysmorphic features are characteristic of Down syndrome.

Conclusions:

  • Individuals with Down syndrome experience substantial burdens from cardiovascular, respiratory, and immune system disorders.
  • Further comparative research on cardiopulmonary diseases in Down syndrome populations is essential.
  • Enhanced understanding of genetic factors can drive novel therapeutic and preventative strategies for millions worldwide.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
687
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
688
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722